Adenovirus-mediated hepatic gene transfer in mice: Comparison of intravascular and biliary administration

Human Gene Therapy

Volumn 7, Issue 14, 1996, Pages 1693-1699

  Vrancken Peeters, Marie Jeanne T F D ^a,b   Patijn, Gijsbert A ^a   Lieber, Andre ^a   Meuse, Leonard ^a   Kay, Mark A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HEPATOBILIARY SYSTEM; IMMUNE RESPONSE; LIVER; MICROSURGERY; MOUSE; NONHUMAN; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA;

EID: 0029822002     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.14-1693     Document Type: Article

References (15)

1. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
2. FANG, B., EISENSMITH, R.C., LI, X.H.C., FINEGOLD, M.J., SHEDLOVSKY, A., DOVE, W., and WOO, S.L.C. (1994). Gene therapy for phenylketonuria: Phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1, 247-254.
3. ISHIBASHI, S., BROWN, M.S., GOLDSTEIN, J.L., GERARD, R.D., HAMMER, R.E., and HERZ, J. (1993). Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery [see comments]. J. Clin. Invest. 92, 883-893.
4. KAY, M.A., and WOO, S.L. (1994). Gene therapy for metabolic disorders. Trends Genet. 10, 253-257.
5. KAY, M.A., LANDEN, C.N., ROTHENBERG, S.R., TAYLOR, L.A., LELAND, F., WIEHLE, S., FANG, B., BELLINGER, D., FINEGOLD, M., THOMPSON, A.R., READ, M., BRINKHOUS, K.M., and WOO, S.L.C. (1994). In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA 91, 2353-2357.
6. KAY, M.A., GRAHAM, F., LELAND, F., and WOO, S.L. (1995a). Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819.
7. KAY, M.A., HOLTERMAN, A.-X., MEUSE, L., GOWN, A., OCHS, H., LINSLEY, P.S., and WILSON, C.B. (1995b). Long-term hepatic adenovirus mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11, 191-197.
8. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
9. LI, Q., KAY, M.A., FINEGOLD, M., STRATFORD PERRICAUDET, L.D., and WOO, S.L. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4, 403-409.
10. SEARLE, P.F., DAVISON, B.L., STUART, G.W., WILKIE, T.M., NORSTEDT, G., and PALMITER, R.D. (1984). Regulation, linkage, and sequence of mouse metallothionein I and II genes. Mol. Cell. Biol. 4, 1221-1230.
11. SMITH, T.A., MEHAFFEY, M.G., KAYDA, D.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., MCCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
12. STRATFORD PERRICAUDET, L.D., MAKEH, I., PERRICAUDET, M., and BRIAND, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90, 626-630.
13. VRANCKEN PEETERS, M.J.T.F.D., LIEBER, A., PERKINS, J., and KAY, M.A. (1996). A method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques 20, 278-285.
14. YANG, Y., RAPER, S.E., COHN, J.A., ENGELHARDT, J.F., and WILSON, J.M. (1993). An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc. Natl. Acad. Sci. USA 90, 4601-4605.
15. YANG, Y., LI, Q., ERTL, H.C., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.